19,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
10 °P sammeln
Andere Kunden interessierten sich auch für
![DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA]( "DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA")
DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA29,99 €![Prosthodontic Implications of Obstructive Sleep Apnea]( "Prosthodontic Implications of Obstructive Sleep Apnea")
Prosthodontic Implications of Obstructive Sleep Apnea51,99 €![Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea]( "Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea")
Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea110,99 €![Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea]( "Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea")
Development of Implantable Electronics as Novel Approaches to Obstructive Sleep Apnea110,99 €![TREATMENT AND DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA]( "TREATMENT AND DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA")
TREATMENT AND DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA40,99 €![Quality of Life In Sleep Apnea Syndrome]( "Quality of Life In Sleep Apnea Syndrome")
Quality of Life In Sleep Apnea Syndrome18,99 €![Prevalence of obstructive sleep apnea in acute coronary syndrome]( "Prevalence of obstructive sleep apnea in acute coronary syndrome")
Prevalence of obstructive sleep apnea in acute coronary syndrome24,99 €
Obstructive sleep apnea (OSA) syndrome is characterized by recurrent episodes of pharyngeal collapses occurring during sleep, leading to chronic intermittent hypoxia (IH). Long time ago, OSA has been recognized as a cardiovascular risk factor. Furthermore, it is associated with increased prevalence of type 2 diabetes and has been shown to be a risk factor for insulin resistance and incident diabetes independently of obesity. Since the benefits of physical activity on cardiometabolic health have been largely recognized and the effects of reference treatment of OSA (Continuous Positive Airway Pressure device) are limited, exercise could limit IH-induced cardiometabolic morbidity in OSA patients. To explore this possibility we conducted 2 studies on human beings and mice in order to characterize physical fitness, fat oxidation capacity, their link with cardiometabolic morbidity in non-obese OSA and to assess the specific effects of IH and the needs in terms of physical activity adaptations. The aims of the second study were to confirm the specific effects of IH on insulin resistance on mice and to explore the possible benefits of different modalities of aerobic exercise training.